SNC-Lavalin Group Inc. (TSE:ATR – Free Report) – Equities researchers at Scotiabank dropped their FY2025 EPS estimates for shares of SNC-Lavalin Group in a note issued to investors on Wednesday, March 19th. Scotiabank analyst J. Goldman now forecasts that the company will post earnings of $2.89 per share for the year, down from their previous estimate of $3.08. Scotiabank also issued estimates for SNC-Lavalin Group’s FY2026 earnings at $3.69 EPS.
Separately, Stifel Canada raised SNC-Lavalin Group to a “strong-buy” rating in a report on Tuesday, February 4th.
SNC-Lavalin Group Price Performance
About SNC-Lavalin Group
AptarGroup, Inc provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage.
Further Reading
- Five stocks we like better than SNC-Lavalin Group
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- Roth IRA Calculator: Calculate Your Potential Returns
- NVIDIA Insiders Sell: This Is What It Means for the Market
- What is Short Interest? How to Use It
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Receive News & Ratings for SNC-Lavalin Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SNC-Lavalin Group and related companies with MarketBeat.com's FREE daily email newsletter.
